International Clinical Trial: Phase II Clinical Study on the Safety and Efficacy of Chemotherapy Regimens Based on Paclitaxel Polymer Micelles for Injection in the Treatment of Metastatic Pancreatic Cancer as Second-Line and Subsequent Therapy

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131381) titled 'Phase II Clinical Study on the Safety and Efficacy of Chemotherapy Regimens Based on Paclitaxel Polymer Micelles for Injection in the Treatment of Metastatic Pancreatic Cancer as Second-Line and Subsequent Therapy' on Sept. 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Hangzhou First People's Hospital

Condition: metastatic pancreatic cancer

Intervention: Cohort A ( second-line treatment cohort ):Polymeric micellar paclitaxel for injection combined with gemcitabine chemotherapy

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-01

Target Sam...